Monday, 16 Sep 2019

Autoimmune/Lupus

Date Typesort ascending Title Save
07 Feb 2017 Social Belimumab RCTs shows promising renal effects. 55% improved renal outcomes, 71% improved proteinura, renal flare=1.7% https://t.co/4VLHmJmIhb
02 Nov 2015 Social Check out the cool, free, slide download on Lupus Skin Disease from RheumNow. https://t.co/P0418gbjDf
29 Apr 2015 Social Alliance for Lupus Research and Janssen w/ do a study of Ustekinumab in SLE later this year http://buff.ly/1HHo9l4 
16 Jan 2019 Social Who thought this was possible? Numbers suggest this is rare. Tis wrong to use this to forge ahead with an unlikely PMR dx in the face of a normal CRP/ESR; but will you go so far as to order the expensive FDG-PET? https://t.co/RTkiUXO7lX
07 Nov 2017 Social RT @WShergy: The forms of exercise most associated with Rhabdomyalysis. acr2017 @rheumnow#2174 https://t.co/hz62eRhyAi
09 Feb 2018 Social Dr Bevra Hahn survival of renal transplant in lupus is good, 80+% at 5yrs. #RWCS https://t.co/OLjxl4YTLr
29 Apr 2017 Social RT @DrRachelTate: Granulomas: macs, T cells and dendritic cells necessary for formation. Dr. Weyand @RheumNow #SOTA2017 https://t.co/7w3DXU…
06 Nov 2017 Social RT @DrRachelTate: Novel Anti-CD40 monoclonal ab CFZ533 potential benefit in Sjogren's Syndrome. #ACR17 @RheumNow #1784 https://t.co/sehIStK…
25 Apr 2016 Social Lancet has published a perspective on Lupus and how it has evolved. https://t.co/qiLeYd0CYO
25 Oct 2018 Social RT @CCalabreseDO: checkpoint inhibitor-related myositis has unique phenotype - myocarditis, myasthenia gravis-like symptoms abstract #2976…
26 Jul 2016 Social CHMP has recommended abatacept for 1st line use (before MTX) in moderate to severe RA. EMA to consider approval https://t.co/kXyD1cXKbO
16 Nov 2016 Social RT @rachelthuston: Key US findings in GCA per #OMERACT #ACR16 @RheumNow https://t.co/Dm1Sr0qOkf https://t.co/9jjzZnozfZ
25 Nov 2015 Social RT @DrPetryna: @RheumNow Vitamin D levels may predict cognitive impairment in patients with #SLE https://t.co/oDI3GtUMvj
10 Nov 2017 Social RT @isa75012: PulmHTN and ILD now leading cause of death in #scleroderma #GR https://t.co/6q2i9yWdB8
30 Apr 2017 Social RT @DrRachelTate: Sicca management options. Pearls: fluoride treatments + monitoring for thrush (Beware: sugar in otc meds!) A. Baer, MD @R…
30 Apr 2016 Social Late onset SLE (>50yrs) patients have less cutaneous dz (malar rash, photosensitivity, livedo) but more Sicca Sx https://t.co/TuqomEgSIa
20 Jul 2018 Social Lancet article - Baricitinib 4 mg (not 2mg) shown to be effective in SLE. After 24 weeks SLEDAI-2K responses were Bari 4 mg 67% vs 53% PB0. https://t.co/KWqMJcDHF2
06 Apr 2017 Social Dr Torgerson Complement deficiency in SLE: C2 40% homozytotes get lupus GN; C4 - 75% get GN; C1q/r/s def 90% get SLE or GN, usually young
18 Mar 2019 Social European Commission Approves MabThera (rituximab) for use in Pemphigus, US FDA approved it in 6/18; RTX is now approved in 4 autoimmune disorders in the US & Europe (RA, GPA, MPA, Pemphigus) - Not approved for use in children https://t.co/dJJfPdXuWQ(rituxim/364143/index.html
31 Oct 2017 Social 18FFDG-PET superior to clinical scoring in Dx of PMR (pre-pred) w/ sensitivity 85%, specificity 87%, PPV 93% NPV 74% https://t.co/11ltSQLkT9